Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Pigment Cell Melanoma Res. 2020 Jul 7;33(6):878–888. doi: 10.1111/pcmr.12909

Figure 2: PFS and OS Stratified by Lymphovascular Invasion.

Figure 2:

(2A): Patients with lymphovascular invasion seen on primary biopsy samples had a significantly longer PFS interval following immunotherapy compared to patients without lymphovascular invasion (p=0.003). (2B): Significant difference in OS in patients with lymphovascular invasion compared to patients without lymphovascular invasion (p=0.036).